


Cypress Bioscience Inc.: Cypress Bioscience, Inc. to Present at Jefferies 3rd Annual Healthcare Conference
SAN DIEGO, CA--(Marketwire - June 16, 2009) - Cypress Bioscience, Inc. (
The Jefferies conference is being held in New York, NY. Ms. Johnson is scheduled to present on Thursday, June 18th at 3:45 p.m. Eastern Time. The audio broadcast of this presentation can be accessed at [ http://www.wsw.com/webcast/jeff35/cypb/ ].
A replay of the presentation will be available at the same web address as well as on Cypress' website, [ http://www.cypressbio.com/events.php ].
About Cypress Bioscience
Cypress Bioscience, Inc. provides therapeutics and personalized medicine services, facilitating improved and individualized patient care. Cypress addresses the evolving needs of specialist physicians and their patients by identifying unmet medical needs in the areas of pain, rheumatology, and physical medicine and rehabilitation, including challenging disorders such as fibromyalgia and rheumatoid arthritis. This approach to improving patient care creates a unique partnership with physicians. Current products include Savella (milnacipran HCI) and the Avise PG(SM) and Avise MCV(SM) therapeutic monitoring, diagnostic and prognostic tests for rheumatoid arthritis.
For more information about Cypress, please visit the Company's website at [ www.cypressbio.com ].